US Bancorp’s iKang Healthcare Group, Inc. KANG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-108
Closed -$2K 3761
2018
Q4
$2K Sell
108
-73
-40% -$1.3K ﹤0.01% 3467
2018
Q3
$3K Buy
181
+73
+68% +$1.41K ﹤0.01% 3468
2018
Q2
$2K Hold
108
﹤0.01% 3525
2018
Q1
$2K Hold
108
﹤0.01% 3519
2017
Q4
$2K Hold
108
﹤0.01% 3507
2017
Q3
$1K Hold
108
﹤0.01% 3548
2017
Q2
$1K Sell
108
-238
-69% -$3.45K ﹤0.01% 3508
2017
Q1
$5K Buy
346
+90
+35% +$1.48K ﹤0.01% 3229
2016
Q4
$4K Buy
+256
New +$4.33K ﹤0.01% 3273
2016
Q3
Sell
-43
Closed -$1K 3686
2016
Q2
$1K Buy
+43
New +$866 ﹤0.01% 3516
2015
Q3
Sell
-59
Closed -$1K 3730
2015
Q2
$1K Buy
+59
New +$1.08K ﹤0.01% 3524

US Bancorp's KANG Position: Q1 2019 in Review

US Bancorp sold out of iKang Healthcare Group, Inc. (KANG) in Q1 2019, closing a stake of 108 shares — an estimated $2K sold.

US Bancorp first reported a position in KANG in Q2 2015 and held it in 11 quarters. The position peaked at $5K in Q1 2017. 0 funds tracked by Wall St. Rank hold KANG as of Q1 2019.

  • US Bancorp reported no remaining iKang Healthcare Group, Inc. position as of Q1 2019 after selling out during the quarter.
  • US Bancorp sold 108 iKang Healthcare Group, Inc. shares in Q1 2019, an estimated $2K.
  • US Bancorp first reported a position in iKang Healthcare Group, Inc. in Q2 2015 and held it in 11 quarters.
  • US Bancorp's iKang Healthcare Group, Inc. position peaked at $5K in Q1 2017.
  • 0 funds tracked by Wall St. Rank held iKang Healthcare Group, Inc. as of Q1 2019.

Based on US Bancorp's 13F filing for Q1 2019, filed 8 May 2019.